Drug‐coated balloon (DCB) percutaneous interventional therapy allows for durable
reopening of the narrowed lumen via physical tissue expansion and local anti‐restenosis …

The most common treatment for obstructive coronary artery disease (CAD) is the
implantation of a permanent drug-eluting stent (DES). Not only has this permanency been …

Drug-coated balloon (DCB) angioplasty is one of the potential approaches to alleviating in-
stent restenosis and treating peripheral artery disease. An in-silico model has been …

Since the introduction of percutaneous coronary intervention (PCI) for the treatment of
obstructive coronary artery disease (CAD), patient outcomes have progressively improved …

In the early years of tissue engineering, scientists focused on the generation of healthy-like
tissues and organs to replace diseased tissue areas with the aim of filling the gap between …

Drug-coated balloons (DCBs) are used commonly for delivering drug into diseased arteries.
When applied on the inner surface of an artery, drug is transported from the balloon into the …

To quantify the biology and physical understanding of endovascular drug delivery, a
mathematical model that accounts for the two-phase binding of drug molecules in a …

In-stent restenosis represents a major cause of failure of percutaneous coronary intervention
with drug-eluting stent implantation. Computational multiscale models have recently …

Objective Drug delivery from a drug-loaded device into an adjacent tissue is a complicated
process involving drug transport through diffusion and advection, coupled with drug binding …

The reduction in the inner diameter of the artery due to the creation of atheromatic plaque on
the artery lumen, known as artery stenosis, disrupts the blood flow, leading to medical …